- 24/7 Wall St.•2 days ago
Puma Biotechnology posted strong gains over the course of this past week, which began with some positive news from the FDA and continued with a huge analyst call.
- Investor's Business Daily•5 days ago
Puma stock rocketed to an eight-month high Thursday after the FDA approved its new drug application for a breast cancer treatment drug.
Puma Biotechnology, Inc. (PBYI)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||69.64 x 300|
|Ask||75.00 x 100|
|Day's Range||67.29 - 69.95|
|52wk Range||19.74 - 94.93|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-8.70|
|Avg Vol (3m)||814,209|
|Dividend & Yield||N/A (N/A)|